$CHMX
NEXT-ChemX Corporation.

2023 Q1 Form 10-K Financial Statement

#000149315223009838 Filed on March 30, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $436.7K $473.0K $1.673M
YoY Change 16.72% -44.32% -5.3%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.330K $1.330K $5.160K
YoY Change 10.83% 10.83% -98.54%
% of Gross Profit
Operating Expenses $436.7K $473.0K $1.673M
YoY Change 16.72% -44.32% -5.3%
Operating Profit -$436.7K -$1.673M
YoY Change 16.72% -5.3%
Interest Expense $21.32K -$26.92K $70.52K
YoY Change -254.72% 21.75% -311.31%
% of Operating Profit
Other Income/Expense, Net -$21.32K -$70.52K
YoY Change 54.71% 304.93%
Pretax Income -$458.0K -$499.9K -$1.744M
YoY Change 18.07% -42.64% -2.27%
Income Tax
% Of Pretax Income
Net Earnings -$458.0K -$499.9K -$1.744M
YoY Change 18.07% -42.64% -2.27%
Net Earnings / Revenue
Basic Earnings Per Share -$0.02 -$0.06
Diluted Earnings Per Share -$0.02 -$0.02 -$0.06
COMMON SHARES
Basic Shares Outstanding 28.85M shares 28.06M shares 27.80M shares
Diluted Shares Outstanding 28.37M shares 27.80M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $142.2K $28.36K $28.36K
YoY Change 690.44% 171.91% 171.91%
Cash & Equivalents $142.2K $28.35K $28.36K
Short-Term Investments
Other Short-Term Assets $13.33K $22.17K $22.17K
YoY Change 733.13% 1285.63% 1285.63%
Inventory
Prepaid Expenses $1.600K
Receivables
Other Receivables
Total Short-Term Assets $155.5K $50.52K $50.52K
YoY Change 693.94% 320.02% 319.95%
LONG-TERM ASSETS
Property, Plant & Equipment $16.62K $17.96K $17.96K
YoY Change -18.27% -16.63% -16.62%
Goodwill
YoY Change
Intangibles $3.150M $3.150M
YoY Change 0.0%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $3.167M $3.168M $3.168M
YoY Change -0.12% -0.11% -0.11%
TOTAL ASSETS
Total Short-Term Assets $155.5K $50.52K $50.52K
Total Long-Term Assets $3.167M $3.168M $3.168M
Total Assets $3.322M $3.219M $3.219M
YoY Change 4.15% 1.1% 1.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $529.6K $1.549M $1.549M
YoY Change 21.54% 99.12% 99.12%
Accrued Expenses $1.150M
YoY Change 86.0%
Deferred Revenue
YoY Change
Short-Term Debt $857.2K $926.0K $926.0K
YoY Change 590.61% 15595.08% 15595.08%
Long-Term Debt Due $0.00 $0.00
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $2.548M $2.487M $2.487M
YoY Change 36.61% 69.03% 69.03%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.548M $2.487M $2.487M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $2.548M $2.487M $2.487M
YoY Change 36.61% 69.03% 69.03%
SHAREHOLDERS EQUITY
Retained Earnings -$4.151M -$3.693M
YoY Change 89.47%
Common Stock $28.45K $28.35K
YoY Change 3.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $773.9K $731.9K $731.9K
YoY Change
Total Liabilities & Shareholders Equity $3.322M $3.219M $3.219M
YoY Change 4.15% 1.1% 1.1%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$458.0K -$499.9K -$1.744M
YoY Change 18.07% -42.64% -2.27%
Depreciation, Depletion And Amortization $1.330K $1.330K $5.160K
YoY Change 10.83% 10.83% -98.54%
Cash From Operating Activities -$310.1K -$446.2K -$935.1K
YoY Change 180.27% 121.88% 32.91%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $1.577K
YoY Change -106.56%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$1.577K
YoY Change -93.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $424.0K 474.5K $954.6K
YoY Change 258.65% 125.51% 37.67%
NET CHANGE
Cash From Operating Activities -$310.1K -446.2K -$935.1K
Cash From Investing Activities 0.000 -$1.577K
Cash From Financing Activities $424.0K 474.5K $954.6K
Net Change In Cash $113.8K 28.26K $17.93K
YoY Change 204.2% -152.43%
FREE CASH FLOW
Cash From Operating Activities -$310.1K -$446.2K -$935.1K
Capital Expenditures $0.00 $1.577K
Free Cash Flow -$310.1K -$446.2K -$936.7K
YoY Change 180.27% 121.88% 37.85%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001657045
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
usd
CY2022Q4 CHMX Convertible Notes Payable Related Party Current
ConvertibleNotesPayableRelatedPartyCurrent
usd
CY2022Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2021 us-gaap Stock Granted During Period Value Sharebased Compensation Forfeited
StockGrantedDuringPeriodValueSharebasedCompensationForfeited
usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2022 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
usd
CY2021 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
usd
CY2021 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
usd
CY2021 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
CY2022 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022 us-gaap Stock Issued1
StockIssued1
usd
CY2022 CHMX Cancellation Of Shares
CancellationOfShares
usd
CY2021 CHMX Common Stock Issued On Conversion Of Third Party Loan
CommonStockIssuedOnConversionOfThirdPartyLoan
usd
CY2021 CHMX Common Stock Issued On Conversion Of Related Party Loan
CommonStockIssuedOnConversionOfRelatedPartyLoan
usd
CY2022 CHMX Related Party Debt Forgiveness
RelatedPartyDebtForgiveness
usd
CY2022Q4 CHMX Deferred Tax Assets Amortization Of Fair Value Of Stock For Services
DeferredTaxAssetsAmortizationOfFairValueOfStockForServices
usd
CY2021Q4 CHMX Deferred Tax Assets Amortization Of Fair Value Of Stock For Services
DeferredTaxAssetsAmortizationOfFairValueOfStockForServices
usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
usd
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
usd
CY2021Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
usd
CY2022Q4 CHMX Deferred Tax Asset Net Non Current
DeferredTaxAssetNetNonCurrent
usd
CY2021Q4 CHMX Deferred Tax Asset Net Non Current
DeferredTaxAssetNetNonCurrent
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
000-56379
CY2022 dei Entity Registrant Name
EntityRegistrantName
NEXT-CHEMX CORPORATION
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
32-0446353
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
901 Mopac Expressway South
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Building 1
CY2022 dei Entity Address Address Line3
EntityAddressAddressLine3
Suite 300
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Austin
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
78746
CY2022 dei City Area Code
CityAreaCode
(512)
CY2022 dei Local Phone Number
LocalPhoneNumber
663-2690
CY2022 dei Security12g Title
Security12gTitle
Common Stock, par value $0.001
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Public Float
EntityPublicFloat
48385381 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
28846834 shares
CY2022 dei Auditor Firm
AuditorFirmId
5041
CY2022 dei Auditor Name
AuditorName
BF Borgers CPA PC
CY2022 dei Auditor Firm
AuditorFirmId
5041
CY2022 dei Auditor Location
AuditorLocation
Lakewood, CO
CY2022Q4 us-gaap Cash
Cash
28355 usd
CY2021Q4 us-gaap Cash
Cash
10429 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
22169 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1600 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
50524 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
12029 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17957 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21540 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3150114 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3150114 usd
CY2022Q4 us-gaap Assets
Assets
3218595 usd
CY2021Q4 us-gaap Assets
Assets
3183683 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1548740 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
777797 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
11980 usd
CY2021Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
672500 usd
CY2021Q4 CHMX Convertible Notes Payable Related Party Current
ConvertibleNotesPayableRelatedPartyCurrent
15000 usd
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
5900 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
926007 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2486727 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1471197 usd
CY2022Q4 us-gaap Liabilities
Liabilities
2486727 usd
CY2021Q4 us-gaap Liabilities
Liabilities
1471197 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28346834 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28346834 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27385437 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27385437 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
28347 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
27385 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4396254 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3634034 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3692732 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1948933 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
731868 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1712486 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3218595 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3183683 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1673284 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1766956 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
1673284 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
1766956 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-1673284 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-1766956 usd
CY2022 us-gaap Interest Expense
InterestExpense
70515 usd
CY2021 us-gaap Interest Expense
InterestExpense
33369 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
15955 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-70515 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-17414 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1743799 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1784370 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1743799 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1784370 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27802153 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21529360 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-154408 usd
CY2021 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
3500127 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1784370 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1712486 usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
686505 usd
CY2022 CHMX Stock Issued During Period Value Conversion Of Related Party
StockIssuedDuringPeriodValueConversionOfRelatedParty
76676 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1743799 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
731868 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1743799 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1784370 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5160 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
352523 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
15955 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
824124 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
743720 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
20570 usd
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-542 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-935085 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-703540 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1577 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24050 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1577 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-24050 usd
CY2021 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
672500 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
60000 usd
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
15000 usd
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1056007 usd
CY2021 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
5900 usd
CY2022 us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
11980 usd
CY2022 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
37500 usd
CY2022 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-130000 usd
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
5900 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
954587 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
693400 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
17925 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-34190 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10429 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
44619 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
28354 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10429 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
14022 usd
CY2021 us-gaap Stock Issued1
StockIssued1
3500127 usd
CY2021 CHMX Cancellation Of Shares
CancellationOfShares
5418 usd
CY2022 CHMX Common Stock Issued On Conversion Of Third Party Loan
CommonStockIssuedOnConversionOfThirdPartyLoan
686505 usd
CY2022 CHMX Common Stock Issued On Conversion Of Related Party Loan
CommonStockIssuedOnConversionOfRelatedPartyLoan
76677 usd
CY2021 CHMX Related Party Debt Forgiveness
RelatedPartyDebtForgiveness
151137 usd
CY2022 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
944173 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28346834 shares
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3692732 usd
CY2022Q4 CHMX Working Capital Deficit
WorkingCapitalDeficit
2436203 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1948933 usd
CY2021Q4 CHMX Working Capital Deficit
WorkingCapitalDeficit
1459168 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_841_eus-gaap--UseOfEstimates_zfhC0wHYt8ej" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Use of Estimates</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
28354 usd
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
10429 usd
CY2022Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
22169 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1600 usd
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
350014 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3150114 usd
CY2022 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1548740 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
777797 usd
CY2022Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
710000 usd
CY2022Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.75
CY2022Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
1.00
CY2022Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
37500 usd
CY2022 us-gaap Interest Expense Debt
InterestExpenseDebt
34365 usd
CY2022Q3 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.12 pure
CY2022Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
555000 usd
us-gaap Debt Instrument Redemption Price Percentage
DebtInstrumentRedemptionPricePercentage
0.08 pure
CY2022Q3 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
20000 usd
CY2022Q4 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
500000 usd
CY2022 us-gaap Debt Instrument Redemption Price Percentage
DebtInstrumentRedemptionPricePercentage
0.10 pure
CY2022 us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
5625.02 usd
CY2022Q4 us-gaap Related Party Transaction Due From To Related Party
RelatedPartyTransactionDueFromToRelatedParty
945124.74 usd
CY2021Q4 us-gaap Related Party Transaction Due From To Related Party
RelatedPartyTransactionDueFromToRelatedParty
420395 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1743799 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1784370 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
775474 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
409276 usd
CY2022Q4 CHMX Deferred Tax Assets Non Current
DeferredTaxAssetsNonCurrent
775474 usd
CY2021Q4 CHMX Deferred Tax Assets Non Current
DeferredTaxAssetsNonCurrent
409276 usd
CY2022Q4 CHMX Deferred Tax Asset Valuation Allowance Noncurrent
DeferredTaxAssetValuationAllowanceNoncurrent
-775474 usd
CY2021Q4 CHMX Deferred Tax Asset Valuation Allowance Noncurrent
DeferredTaxAssetValuationAllowanceNoncurrent
-409276 usd
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27385437 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28346834 shares

Files In Submission

Name View Source Status
0001493152-23-009838-index-headers.html Edgar Link pending
0001493152-23-009838-index.html Edgar Link pending
0001493152-23-009838.txt Edgar Link pending
0001493152-23-009838-xbrl.zip Edgar Link pending
chmx-20221231.xsd Edgar Link pending
ex10-1.htm Edgar Link pending
ex10-2.htm Edgar Link pending
ex10-3.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
chmx-20221231_cal.xml Edgar Link unprocessable
chmx-20221231_def.xml Edgar Link unprocessable
chmx-20221231_lab.xml Edgar Link unprocessable
chmx-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending